US Patent 10668170 Modified RNAi agents
Patent 10668170 was granted and assigned to Alnylam Pharmaceuticals on June, 2020 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
October 19, 2018
Date of Patent
June 2, 2020
Patent Applicant
Patent Application Number
16165343
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10668170 Modified RNAi agents
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
